Study investigators suggest that annual CD4 cell count monitoring in virally suppressed HIV patients with a CD4 count of 250 cells/μl or greater at baseline appears to be sufficient for clinical management. No significant differences were observed in time to a confirmed CD4 cell count of less than 200 cells/μl between annual and biannual monitoring.
Source: Journal of Acquired Immune Deficiency Syndromes, July 1, 2015.
An abstract of the study is available at http://journals.lww.com/jaids/Abstract/2015/07010/Implementation_and_Operational_Research___Effects.13.aspx.
